Breast Neoplasms: all 12,820 studies
Page 23 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer PatientsRecruitingNCT05732051Phase 2
- Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin RegimenRecruitingNCT05731258
- 18F-FDG PET/CT Imaging for Breast CancerRecruitingNCT05730608Not applicable
- Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation IndexRecruitingNCT05728268Phase 2
- 4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers RadiotherapyRecruitingNCT05726604Not applicable
- LLLT for BCRL: a Randomized, Placebo-controlled StudyRecruitingNCT05725265Not applicable
- Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)RecruitingNCT05722795Not applicable
- With Love, Grandma ("Con Cariño, Abuelita") Pilot StudyRecruitingNCT05721976Not applicable
- Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBCRecruitingNCT05720260Phase 2
- Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast CancerRecruitingNCT05720026Phase 3
- Study of Aerobic Training for People Receiving Treatment for Breast CancerRecruitingNCT05716893Phase 2
- STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)RecruitingNCT05716516Phase 2
- Thoracic Paravertebral Block Anesthesia for Breast Cancer SurgeryRecruitingNCT05711030Not applicable
- Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During ChemotherapyRecruitingNCT05704842Not applicable
- 3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast CancerRecruitingNCT05704283Early Phase 1
- PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer PatientsRecruitingNCT05704166Phase 2
- Quantitative MRI Assessment of Breast Cancer Therapy ResponseRecruitingNCT05704062
- Thero2-01S22 in HER2-positive Breast CancerNot yet recruitingNCT05698186Phase 3
- Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationRecruitingNCT05696626Phase 3
- Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and TelegeneticsRecruitingNCT05694559Not applicable
- Gene Signatures to Guide HR+MBC Therapy in a Diverse CohortRecruitingNCT05693766Phase 2
- A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation ReconstructionRecruitingNCT05692674Phase 2
- A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast CancerRecruitingNCT05692661Phase 1
- SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)RecruitingNCT05689619Not applicable
- Rehabilitation on Equal Terms - The ReMig StudyRecruitingNCT05689398
- Microscopy Imaging of Whole-mount Stained Human TissuesRecruitingNCT05689112
- Exercise to ReGain Stamina and Energy (The EXERGISE Study)RecruitingNCT05684367Not applicable
- A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast CancerRecruitingNCT05683418Phase 1
- Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer PatientsRecruitingNCT05680194
- Evaluation of the Interest of a Postural and Functional Analysis for the Follow-up of the Adapted Motor Activity of Patients Treated for Breast CancerRecruitingNCT05677022Not applicable
- Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant TherapyNot yet recruitingNCT05676866Phase 4
- To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.RecruitingNCT05673694Phase 1
- Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast CancerRecruitingNCT05673629Phase 3
- Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast CancerRecruitingNCT05673304Not applicable
- The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense BreastsRecruitingNCT05667532Not applicable
- Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated RadiotherapyRecruitingNCT05665920Not applicable
- Catheter Guided Chemo-infusion in Breast CancerNot yet recruitingNCT05661656Not applicable
- Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)RecruitingNCT05660083Phase 2
- FES BPET-DBT in Newly Diagnosed Breast CancerRecruitingNCT05659797Early Phase 1
- Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast CancerRecruitingNCT05659056Phase 2
- Program of Physical Activity, Nutrition and Supportive to Improve the Quality of Life of Breast Cancer SurvivorsRecruitingNCT05658341Not applicable
- Standard Surveillance vs. Intensive Surveillance in Early Breast CancerRecruitingNCT05658172Not applicable
- Multimodal ProjectRecruitingNCT05656716Not applicable
- To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical StudyRecruitingNCT05656079Not applicable
- A Multilevel Approach to Connecting Underrepresented Populations to Clinical TrialsRecruitingNCT05655494
- Weight Loss and Breast CancerNot yet recruitingNCT05654571
- Susan G. Komen's ShareForCuresRecruitingNCT05654246
- VR-based Intervention for Cognitive RestorationRecruitingNCT05653596Not applicable
- CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast CancerRecruitingNCT05652569
- Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant TherapyRecruitingNCT05649475
- Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.RecruitingNCT05649072Not applicable
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination TherapyRecruitingNCT05646862Phase 3
- Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA StudyEnrolling by invitationNCT05645536Phase 3
- LIVInG With chrONic Cancer TrEatments (LONGEVITI) StudyRecruitingNCT05645510
- Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)RecruitingNCT05640778Phase 2
- Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast CancerRecruitingNCT05638594Phase 2
- Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant ChemotherapyRecruitingNCT05636644
- A Study of SHR-A1811 Monotherapy or Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer PatientsRecruitingNCT05635487Phase 2
- The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.RecruitingNCT05634889Not applicable
- Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast CancerRecruitingNCT05633914Phase 2
- Olaparib Maintenance Therapy in Metastatic Breast CancerRecruitingNCT05629429Phase 2
- A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast CancerRecruitingNCT05628870Phase 1
- First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor MalignanciesRecruitingNCT05627960Phase 1
- Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense BreastsRecruitingNCT05625659Not applicable
- MONOCENTRIC PERSPECTIVE STUDY: USE OF LIQUID BIOPSY WITH DIAGNOSTIC IMAGINGRecruitingNCT05623241
- Pre-operative Therapy in Breast CancerRecruitingNCT05621564
- A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast CancerNot yet recruitingNCT05621434Phase 2
- UNC Pleural Fluid RegistryRecruitingNCT05620329
- Metabolomic Evaluation of Psycho-surgical Synergy on Body Image Restoration After Breast CancerRecruitingNCT05616988Not applicable
- Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.Not yet recruitingNCT05613504Not applicable
- VS-6766+Abema+Fulv in Met HR+/HER- BCRecruitingNCT05608252Phase 1/2
- A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)RecruitingNCT05603078Not applicable
- Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast CancerRecruitingNCT05601440Phase 2
- Global Cardio Oncology RegistryRecruitingNCT05598879
- SNF Platform Study of HR+/ HER2-advanced Breast CancerRecruitingNCT05594095Phase 2
- Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)RecruitingNCT05592938Not applicable
- Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase InhibitorsRecruitingNCT05590949
- Monitoring of Chronic Conditions in Breast CancerRecruitingNCT05587777
- Ultra-hypofractionated Radiotherapy in Breast Cancer PatientsRecruitingNCT05586256
- Opioid Dispensing Device for Post-Operative Pain in Cancer PatientsRecruitingNCT05585788Not applicable
- A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients.RecruitingNCT05585476Not applicable
- Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock WavesRecruitingNCT05584163Not applicable
- Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant TherapyRecruitingNCT05582499Phase 2
- Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer PatientsRecruitingNCT05580887
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)RecruitingNCT05579366Phase 1/2
- Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast CancerRecruitingNCT05578053
- Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)Not yet recruitingNCT05577923Phase 2
- Telemonitoring Hypertension and Breast CancerRecruitingNCT05574686Not applicable
- PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab DeruxtecanRecruitingNCT05573893
- Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast CancerRecruitingNCT05573126Phase 1/2
- A Study of SDX-7320 in Combination With Eribulin for People With Breast CancerRecruitingNCT05570253Phase 2
- Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)RecruitingNCT05561842
- Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast CancerNot yet recruitingNCT05561686
- A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR AlterationsRecruitingNCT05560334Phase 2
- Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI TherapyNot yet recruitingNCT05560308Not applicable
- MEthods for LOcalization of Different Types of Breast LesionsRecruitingNCT05559411
- Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedRecruitingNCT05559164Phase 2
- Low Dose Aspirin for the Prevention of Postpartum Related Breast CancerRecruitingNCT05557877Phase 2
- A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILsRecruitingNCT05556200Phase 2
- Estrogen Receptor (ER) PET/CT Imaging in Breast CancerRecruitingNCT05541367